Stock Analysis

Shanghai Pioneer Holding Full Year 2024 Earnings: EPS: CN¥0.13 (vs CN¥0.12 in FY 2023)

SEHK:1345
Source: Shutterstock
Advertisement

Shanghai Pioneer Holding (HKG:1345) Full Year 2024 Results

Key Financial Results

  • Revenue: CN¥1.53b (down 2.3% from FY 2023).
  • Net income: CN¥151.6m (up 4.0% from FY 2023).
  • Profit margin: 9.9% (in line with FY 2023).
  • EPS: CN¥0.13 (up from CN¥0.12 in FY 2023).
revenue-and-expenses-breakdown
SEHK:1345 Revenue and Expenses Breakdown May 5th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

The primary driver behind last 12 months revenue was the Products Sold via The Provision of Comprehensive Marketing, Promotion and Channel Management Services segment contributing a total revenue of CN¥1.24b (81% of total revenue). Notably, cost of sales worth CN¥847.8m amounted to 55% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Sales & Marketing costs, amounting to CN¥363.2m (68% of total expenses). Explore how 1345's revenue and expenses shape its earnings.

Shanghai Pioneer Holding's share price is broadly unchanged from a week ago.

Risk Analysis

It is worth noting though that we have found 1 warning sign for Shanghai Pioneer Holding that you need to take into consideration.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SEHK:1345

Shanghai Pioneer Holding

An investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People’s Republic of China.

Excellent balance sheet with proven track record.

Advertisement